Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3342645
Max Phase: Preclinical
Molecular Formula: C67H78N22O13
Molecular Weight: 1399.50
Molecule Type: Small molecule
Associated Items:
ID: ALA3342645
Max Phase: Preclinical
Molecular Formula: C67H78N22O13
Molecular Weight: 1399.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H](CCNC(=O)c1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4nccn4C)cn3C)cn2C)cn1C)C(=O)Nc1cnc(C(=O)Nc2cc(C(=O)Nc3cc(C(=O)Nc4cc(C(=O)NCCCN(C)CCCN[14C](=O)c5cccc([14C](=O)O)c5)n(C)c4)n(C)c3)n(C)c2)n1C
Standard InChI: InChI=1S/C67H78N22O13/c1-38(90)73-47(16-19-71-60(94)49-26-42(33-84(49)5)75-62(96)51-27-43(34-86(51)7)76-63(97)52-29-45(36-87(52)8)78-65(99)55-68-20-23-82(55)3)58(92)80-54-31-72-56(89(54)10)66(100)79-46-30-53(88(9)37-46)64(98)77-44-28-50(85(6)35-44)61(95)74-41-25-48(83(4)32-41)59(93)70-18-13-22-81(2)21-12-17-69-57(91)39-14-11-15-40(24-39)67(101)102/h11,14-15,20,23-37,47H,12-13,16-19,21-22H2,1-10H3,(H,69,91)(H,70,93)(H,71,94)(H,73,90)(H,74,95)(H,75,96)(H,76,97)(H,77,98)(H,78,99)(H,79,100)(H,80,92)(H,101,102)/t47-/m1/s1/i57+2,67+2
Standard InChI Key: QQASMNUBKLRIJX-MLAJZKQWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1399.50 | Molecular Weight (Monoisotopic): 1398.6119 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Raskatov JA, Szablowski JO, Dervan PB.. (2014) Tumor xenograft uptake of a pyrrole-imidazole (Py-Im) polyamide varies as a function of cell line grafted., 57 (20): [PMID:25238175] [10.1021/jm500964c] |
Source(1):